Organogenesis
This article was originally published in The Gray Sheet
Executive Summary
Return of Apligraf bi-layered, living skin substitute to the market will be sought under a chapter 11 bankruptcy reorganization plan filed Sept. 25 in Boston federal court. An exclusive distribution pact with Novartis was terminated earlier this month when the parties failed to agree on an amended arrangement (1"The Gray Sheet" Sept. 16, 2002, In Brief). The Canton, Massachusetts firm's workforce was subsequently cut from 125 to 15...